|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�����,��ɫ |
|
��¶������ |
|
��¶�ǵ��� |
|
�Ͼ����� |
|
����ø�� |
| ��������������� | |
|
����� |
|
��³ |
| PubMed | |
|
Article by |
|
Article by |
�������ϵͳ�Ը�Ⱦ�а��������ؿ�ԭ��������
�����, ��³
������ҽ��ѧ����ҽԺƤ���� ���� 400038
��¶���Ǻ�¶�ǵ��ס��Ͼ��ǡ�ϩ����ø����֬ø�͵���ø���ǰ���������ڻ�ϸ���ڵijɷ֡����о�������ѧ���Լ�����Ϊ�ڸ�Ⱦ���������е������Ա�־�������ϵͳ���������Ⱦ�еķ�������ֵ������ȷ������������
[2] Moter A, Gobel UB. Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J Microbiol Methods, 2000,41:85-112.
[3] Marot-Leblond A, Grimaud L, Nail S, et al. New monoclonal antibody specific for Candida albicans germ tube. J Clin Microbiol, 2000,38:61-67.
[4] Persat F, Topenot R, Piens MA, et al. Evaluation of different commercial ELISA methods for the serodiagnosis of systemic candidosis.Mycoses, 2002, 45:455-460.
[5] Han Y, Morrison RP, Cutler JE. A vaccine and monoclonal antibodies that enhance nouse resistance to Candida albicans vaginal infection. Infect Immun, 1998, 66:5771-5776.
[6] Bromuro C, Torosantucci A, Chiani P, et al. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Infect Immun, 2002, 70:5462-5470.
[7] Forsyth CB, Mathews HL. Lymphocyte adhesion to Candida albicans.Infect Immun, 2002, 70:517-527.
[8] Reiss E, Obayashi T, Orle K, et al. Non-culture based diagnostic tests for mycotic infections. Med Mycol, 2000,38:147.
[9] Obayashi T, Yoshida M, Mori T, et al. Plasma (1-�� 3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet, 1995, 345:17-20.
[10] Sundstrom P, Jensen J, Balish E. Hnmoral and cellular imnune responses to enolase after alimentary tract colonization or intravenous immunization with Candida albicans. J Infect Dis, 1994, 170:390.
[11] Sugiyama Y, Nakashima S, Mirbod F, et al. Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans. Med Mycol, 1999, 37:61-67.
[12] Leidich SD, Ibrahim AS, Fu Y,et al. Cloning andi disruption of caPLBl, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem, 1998, 273:26078-26086.
[13] Bennett DE, McCreary CE, Coleman DC. Genetic characterization of a phospholipase C gene from Candida albicans: presence of homologous sequences in Candida species other than Candida albicans. Microbiology, 1998, 144:55-72.
[14] Kanoh H, Nakashima S, Zhao Y, et al. Molecular cloning of a gene encoding phospholipase D from the pathogenic and dimorphic fungus,Candida albicans. Biochim Biophys Acta, 1998, 1398:359-364.
[15] Kothavade R J, Panthaki MH. Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice. J Med Microbiol, 1998, 47:99-102.
[16] Kantarcioglu AS, Yucel A. Phospholipase and protease activities in clinical Candida isolates ith reference to the sources of strains. Mycoses, 2002, 45:160-165.
[17] De Bemardis F, Sullivan PA, Cassone A. Aspartyl proteinases of Candida albieans and their role in pathogenicity. Med Mycol, 2001,39:303-313.
[18] Sandini S, Melchionna R, Arancia S, et al. Generation of a highly immunogenic recombinant enolase of the human opportunistic pathogen Candida albicans. Biotechnol Appl Biochem, 1999, 29:223.